{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:12:23Z","timestamp":1786975943797,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd011804","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000}}],"reference-count":84,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011804.pub2","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T07:51:28Z","timestamp":1464853888000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antipsychotics for fibromyalgia in adults"],"prefix":"10.1002","volume":"2016","author":[{"given":"Brian","family":"Walitt","sequence":"first","affiliation":[{"name":"National Institutes of Health; National Center for Complementary and Integrative Health; 10 Center Drive Bethesda MD USA 20892"},{"name":"National Institutes of Health; National Institute of Nursing Research; 10 Center Drive Bethesda MD USA 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Klose","sequence":"additional","affiliation":[{"name":"University of Duisburg-Essen; Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine; Am Deimelsberg 34 a Essen Germany D-45276"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurcan","family":"\u00dc\u00e7eyler","sequence":"additional","affiliation":[{"name":"University of W\u00fcrzburg; Department of Neurology; W\u00fcrzburg Germany 97080"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor","family":"Phillips","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Churchill Hospital Oxford UK OX3 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"H\u00e4user","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen; Department of Psychosomatic Medicine and Psychotherapy; Langerstr. 3 M\u00fcnchen Germany D-81675"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"key":"10.1002\/14651858.CD011804.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00213-013-3422-0","article-title":"Quetiapine extended-release (Seroquel-XR) versus amitriptyline monotherapy for treating patients with fibromyalgia: a 16-week, randomized, flexible-dose, open-label trial","volume":"231","author":"Calandre","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0002|cit2","first-page":"455","article-title":"Quetiapine fumarate extended-release for the treatment of major depression with comorbid fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study","volume":"66","author":"McIntyre","year":"2014","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0003|cit3","unstructured":"NCT01458964 Quetiapine compared with placebo in the management of fibromyalgia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01458964?term=quetiapine+and+fibromyalgia&rank=3"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0b013e318267b8ca","article-title":"Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial","volume":"32","author":"Potvin","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0013-4694(80)90324-7","article-title":"The relationship of alpha and delta EEG frequencies to pain and mood in 'fibrositis' patients treated with chlorpromazine and L-tryptophan","volume":"50","author":"Moldofsky","year":"1980","journal-title":"Electroencephalography Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"485272","DOI":"10.1155\/2013\/485272","article-title":"Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies","volume":"2013","author":"Ablin","year":"2013","journal-title":"Evidence Based Complementary Alternative Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011804.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.encep.2013.11.002","article-title":"Treatment-resistant anxiety disorders: a literature review of drug therapy strategies","volume":"41","author":"Ammar","year":"2015","journal-title":"Encephale"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.37842","article-title":"The fibromyalgia family study: a genome-wide linkage scan study","volume":"65","author":"Arnold","year":"2013","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3899\/jrheum.081090","article-title":"Minimal clinically important difference in the fibromyalgia impact questionnaire","volume":"36","author":"Bennett","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","article-title":"Pathophysiology of fibromyalgia","volume":"122","author":"Bradley","year":"2009","journal-title":"American Journal Medicine"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/11597130-000000000-00000","article-title":"The role of antipsychotics in the management of fibromyalgia","volume":"26","author":"Calandre","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jpain.2010.01.267","article-title":"The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study","volume":"11","author":"Choi","year":"2010","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0014|cit14","unstructured":"Cochrane Pain Palliative & Supportive Care Review Group PaPaS Author and Referee Guidance. Authoring or assessing a Cochrane Protocol, Review, or Review Update for the PaPaS Review Group. Document version 1. September 2011 http:\/\/papas.cochrane.org\/papas-documents"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0015|cit15","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1998"},{"issue":"2","key":"10.1002\/14651858.CD011804.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17540","article-title":"Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation","volume":"17","author":"Edwards","year":"2013","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00482-012-1167-z","article-title":"Fibromyalgia syndrome. General principles and coordination of clinical care and patient education","volume":"26","author":"Eich","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11136-013-0443-4","article-title":"Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences","volume":"23","author":"Fayers","year":"2014","journal-title":"Quality Life Research"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Research Management"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0021|cit21","first-page":"2458","article-title":"Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study","volume":"26","author":"Forseth","year":"1999","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analyses","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00482-013-1323-0","article-title":"Mental disorders in patients with fibromyalgia syndrome: screening in centres of different medical specialties","volume":"27","author":"Galek","year":"2013","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0024|cit24","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro Guideline Development Tool 2015"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0027|cit27","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/acr.20328","article-title":"Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"63","author":"H\u00e4user","year":"2011","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.pain.2013.03.034","article-title":"Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome","volume":"154","author":"H\u00e4user","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD011804.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/j.1532-2149.2014.00453.x","article-title":"Fibromyalgia syndrome - a somaform disorder?","volume":"18","author":"H\u00e4user","year":"2014","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"1","author":"H\u00e4user","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00482-014-1462-y","article-title":"Methodology of the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain","volume":"29","author":"H\u00e4user","year":"2015","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD011804.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010628.pub2","article-title":"Pharmacological interventions for somatoform disorders in adults","author":"Kleinst\u00e4uber","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00482-010-0937-8","article-title":"Influence of depression on fibromyalgia: a systematic review","volume":"24","author":"Lange","year":"2010","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/2046-4053-2-81","article-title":"Assessing and presenting summaries of evidence in Cochrane Reviews","volume":"2","author":"Langendam","year":"2013","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00296-010-1678-9","article-title":"Candidate gene studies of fibromyalgia: a systematic review and meta-analysis","volume":"32","author":"Lee","year":"2012","journal-title":"Rheumatology International"},{"issue":"1","key":"10.1002\/14651858.CD011804.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0041|cit41","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2318-29","DOI":"10.3899\/jrheum.090367","article-title":"Fibromyalgia Syndrome Module at OMERACT 9","volume":"36","author":"Mease","year":"2009","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD011804.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0044|cit44","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD011804.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011804.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011804.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD011804.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011804.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011804.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011804.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD011804.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD011804.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD011804.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011804.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"7","key":"10.1002\/14651858.CD011804.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011824","article-title":"Amitriptyline for fibromyalgia in adults","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/acr.20118","article-title":"Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Tr\u00f8ndelag Health Study","volume":"62","author":"Mork","year":"2010","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.33346","article-title":"Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway","volume":"64","author":"Mork","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00005650-200110000-00002","article-title":"Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life","volume":"39","author":"Norman","year":"2001","journal-title":"Medical Care"},{"issue":"1","key":"10.1002\/14651858.CD011804.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/JPR.S55598","article-title":"The association between chronic pain and obesity","volume":"14","author":"Okifuji","year":"2015","journal-title":"Journal Pain Research"},{"issue":"8","key":"10.1002\/14651858.CD011804.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Current Pain and Headache Reports"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0065|cit65","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1358\/dot.2014.50.6.2127023","article-title":"Current status of atypical antipsychotics for the treatment of fibromyalgia","volume":"50","author":"Rico-Villademoros","year":"2014","journal-title":"Drugs Today"},{"issue":"8","key":"10.1002\/14651858.CD011804.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004844.pub3","article-title":"Antipsychotics for acute and chronic pain in adults","author":"Seidel","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00482-012-1174-0","article-title":"Etiology and pathophysiology of fibromyalgia syndrome","volume":"26","author":"Sommer","year":"2012","journal-title":"Schmerz"},{"issue":"2","key":"10.1002\/14651858.CD011804.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2474-12-125","article-title":"Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response","volume":"12","author":"Straube","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fnins.2015.00297","article-title":"Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management","volume":"9","author":"Ventriglio","year":"2015","journal-title":"Frontiers in Neuroscience"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/WNF.0b013e3182aa365f","article-title":"Atypical antipsychotics in the treatment of posttraumatic stress disorder","volume":"36","author":"Wang","year":"2013","journal-title":"Clinical Neuropharmacology"},{"issue":"11","key":"10.1002\/14651858.CD011804.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD011804.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"645","author":"Wolfe","year":"2013","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"11","key":"10.1002\/14651858.CD011804.pub2-BIB0082|cit82","first-page":"pyv060","article-title":"Atypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysis","volume":"18","author":"Zhou","year":"2015","journal-title":"International Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD011804.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1093\/brain\/awt115","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1002\/14651858.CD011804.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010782","article-title":"Anticonvulsants for fibromyalgia","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011804.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T13:17:43Z","timestamp":1689081463000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011804.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":84,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011804.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]}}}